Cite
Does bortezomib influence pre-transplant desensitization therapy or benefit post-heart transplant outcomes for highly sensitized patients?
MLA
Dhillon, Manvir, et al. “Does Bortezomib Influence Pre-Transplant Desensitization Therapy or Benefit Post-Heart Transplant Outcomes for Highly Sensitized Patients?” Clinical Transplantation, vol. 38, no. 1, Jan. 2024, p. e15165. EBSCOhost, https://doi.org/10.1111/ctr.15165.
APA
Dhillon, M., Kobashigawa, J. A., Kittleson, M., Jain, R., Patel, N., Singer-Englar, T., Zhang, X., Hakimi, M., Aintablian, T., Vescio, R., Dilibero, D., Kransdorf, E., Czer, L., Nikolova, A. P., & Patel, J. K. (2024). Does bortezomib influence pre-transplant desensitization therapy or benefit post-heart transplant outcomes for highly sensitized patients? Clinical Transplantation, 38(1), e15165. https://doi.org/10.1111/ctr.15165
Chicago
Dhillon, Manvir, Jon A Kobashigawa, Michelle Kittleson, Rashmi Jain, Nikhil Patel, Tahli Singer-Englar, Xiaohai Zhang, et al. 2024. “Does Bortezomib Influence Pre-Transplant Desensitization Therapy or Benefit Post-Heart Transplant Outcomes for Highly Sensitized Patients?” Clinical Transplantation 38 (1): e15165. doi:10.1111/ctr.15165.